QuidelOrtho Statistics
Total Valuation
QuidelOrtho has a market cap or net worth of $2.29 billion. The enterprise value is $5.05 billion.
Important Dates
The next estimated earnings date is Wednesday, February 11, 2026, after market close.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
QuidelOrtho has 67.93 million shares outstanding. The number of shares has increased by 0.93% in one year.
| Current Share Class | 67.93M |
| Shares Outstanding | 67.93M |
| Shares Change (YoY) | +0.93% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 0.94% |
| Owned by Institutions (%) | 114.66% |
| Float | 62.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 15.84 |
| PS Ratio | 0.84 |
| Forward PS | 0.81 |
| PB Ratio | 1.12 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 61.77 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.86 |
| EV / EBITDA | 8.74 |
| EV / EBIT | 35.68 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 1.41.
| Current Ratio | 1.78 |
| Quick Ratio | 0.80 |
| Debt / Equity | 1.41 |
| Debt / EBITDA | 4.51 |
| Debt / FCF | n/a |
| Interest Coverage | 0.78 |
Financial Efficiency
Return on equity (ROE) is -45.16% and return on invested capital (ROIC) is 1.63%.
| Return on Equity (ROE) | -45.16% |
| Return on Assets (ROA) | 1.42% |
| Return on Invested Capital (ROIC) | 1.63% |
| Return on Capital Employed (ROCE) | 2.89% |
| Revenue Per Employee | $411,273 |
| Profits Per Employee | -$178,712 |
| Employee Count | 6,600 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.41 |
Taxes
In the past 12 months, QuidelOrtho has paid $43.30 million in taxes.
| Income Tax | 43.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.91% in the last 52 weeks. The beta is 0.59, so QuidelOrtho's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -26.91% |
| 50-Day Moving Average | 27.00 |
| 200-Day Moving Average | 28.25 |
| Relative Strength Index (RSI) | 72.76 |
| Average Volume (20 Days) | 838,759 |
Short Selling Information
The latest short interest is 11.33 million, so 16.68% of the outstanding shares have been sold short.
| Short Interest | 11.33M |
| Short Previous Month | 11.48M |
| Short % of Shares Out | 16.68% |
| Short % of Float | 18.09% |
| Short Ratio (days to cover) | 10.26 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of $2.71 billion and -$1.18 billion in losses. Loss per share was -$17.44.
| Revenue | 2.71B |
| Gross Profit | 1.28B |
| Operating Income | 141.60M |
| Pretax Income | -1.14B |
| Net Income | -1.18B |
| EBITDA | 577.70M |
| EBIT | 141.60M |
| Loss Per Share | -$17.44 |
Full Income StatementBalance Sheet
The company has $99.00 million in cash and $2.87 billion in debt, with a net cash position of -$2.77 billion or -$40.72 per share.
| Cash & Cash Equivalents | 99.00M |
| Total Debt | 2.87B |
| Net Cash | -2.77B |
| Net Cash Per Share | -$40.72 |
| Equity (Book Value) | 2.04B |
| Book Value Per Share | 29.99 |
| Working Capital | 598.80M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $37.00 million and capital expenditures -$190.10 million, giving a free cash flow of -$153.10 million.
| Operating Cash Flow | 37.00M |
| Capital Expenditures | -190.10M |
| Free Cash Flow | -153.10M |
| FCF Per Share | -$2.25 |
Full Cash Flow StatementMargins
Gross margin is 47.24%, with operating and profit margins of 5.22% and -43.45%.
| Gross Margin | 47.24% |
| Operating Margin | 5.22% |
| Pretax Margin | -41.86% |
| Profit Margin | -43.45% |
| EBITDA Margin | 21.28% |
| EBIT Margin | 5.22% |
| FCF Margin | n/a |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.93% |
| Shareholder Yield | n/a |
| Earnings Yield | -51.61% |
| FCF Yield | -6.70% |
Dividend DetailsAnalyst Forecast
The average price target for QuidelOrtho is $39.33, which is 16.90% higher than the current price. The consensus rating is "Hold".
| Price Target | $39.33 |
| Price Target Difference | 16.90% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 2.41% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
QuidelOrtho has an Altman Z-Score of 0.86 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.86 |
| Piotroski F-Score | 5 |
